aportes a la gestión necesaria para la sustentabilidad de la SALUD PÚBLICA como figura esencial de los servicios sociales básicos para la sociedad humana, para la familia y para la persona como individuo que participa de la vida ciudadana.
miércoles, 11 de septiembre de 2024
Streamlining Drug Development and Improving Patient Care: CDER Quantitative Medicine Center of Excellence
https://www.fda.gov/drugs/cder-conversations/streamlining-drug-development-and-improving-patient-care-cder-quantitative-medicine-center?utm_medium=email&utm_source=govdelivery
CDER Conversation: Streamlining Drug Development and Improving Patient Care: CDER Quantitative Medicine Center of Excellence
In this CDER Conversation, Rajanikanth Madabushi, lead for CDER’s Quantitative Medicine (QM) Center of Excellence (CoE) and associate director for Guidance and Scientific Policy in the Office of Clinical Pharmacology in the Office of Translational Science Super Office explains the purpose of the new CoE, provides an overview of current activities and resources, and shares ways the CoE can advance drug development and improve patient care.
No hay comentarios:
Publicar un comentario